Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, and Hepatitis C virus research.
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas
NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis
p38α Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen Species